By Sabela Ojea
Atea Pharmaceuticals cut its workforce by around 25% during the first quarter.
The clinical-stage biopharmaceutical company on Thursday said that the cuts, aimed at enhancing efficiency across its expenditure structure, are expected to lead to savings of around $15 million through 2027.
As of March 4, Atea Pharmaceuticals had 56 full-time employees.
The cuts came after the company logged a narrower loss for the fourth quarter.
Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix
(END) Dow Jones Newswires
March 06, 2025 17:28 ET (22:28 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。